Becker's Hospital Review | Healthcare News & Analysis

Author's posts

Duke Lifepoint hospital names CEO, chief nursing officer

Central Carolina Hospital in Sanford, N.C., has appointed Dave Santoemma as CEO and Connette Gill, MSN, RN, as chief nursing officer, effective April 1. Both leaders previously held the positions in an interim capacity. 

4 exec exits in 2 days

The end of March brought a flurry of hospital and health system executive exits. 

Measles cases jump 51% in 1 week, CDC data shows

Measles cases have increased sharply in the U.S. over the past week, new CDC data shows. 

Ballad taps chief growth officer

Bo Wilkes was named chief growth officer for Ballad Health, a 21-hospital health system based in Johnson City, Tenn.

1,400+ MultiCare workers cancel strike

Members of SEIU Healthcare 1199NW have called off a seven-day strike that was set to begin April 7 at MultiCare Deaconess Hospital in Spokane, Wash., and MultiCare Valley Hospital in Spokane Valley, Wash., according to hospital and union statements sha…

NYU Langone plans $22M transplant center upgrades

New York City-based NYU Langone Hospital filed a certificate of need application with the New York State Department of Health March 28 to consolidate its transplant services with nearly $22 million in renovation upgrades.

Change hack won't affect nonprofit hospitals' credit: Fitch

Nonprofit hospitals will not face credit impact from the Feb. 21 cyberattack on UnitedHealthcare subsidiary Change Healthcare, according to Fitch. 

UCI Health to install Epic EHR at former Tenet facilities

Orange, Calif.-based UCI Health will transition four former Tenet hospitals to an Epic EHR system.

Best, worst cities to retire with $0 in savings

More than a quarter of Americans haven’t contributed a penny to retirement savings accounts. But there are still many cities where they can retire on a budget — specifically in Arkansas, according to a new analysis from GoBankingRates.  

Up to 15% of patients on weight loss drugs may be 'non-responders'

Physicians estimate up to 15% of people who try GLP-1s — the popular class of anti-obesity medications that includes drugs that include Ozempic and Wegovy — lose less than 5% of their body weight, The Wall Street Journal reported April 1.